Table 1 Patient characteristics
Variable | Overall (N = 69) | |
|---|---|---|
n | (%) | |
Age (years)—median (min–max) | 69 | (36–73) |
Sex | ||
Female | 16 | (23.2%) |
Male | 53 | (76.8%) |
Tumour IIIb stage | ||
T1 N3 M0 | 5 | (7.2%) |
T2 N3 M0 | 18 | (26.1%) |
T3 N3 M0 | 4 | (5.8%) |
T4 N0 M0 | 18 | (26.1%) |
T4 N1 M0 | 2 | (2.9%) |
T4 N2 M0 | 17 | (24.6%) |
T4 N3 M0 | 5 | (7.2%) |
Lymph-node staging by mediastinoscopy | ||
No | 1 | (1.4%) |
Yes | 57 | (82.6%) |
Not available | 11 | (15.9%) |
Patient considered operable | ||
Yes | 69 | (100.0%) |
WHO PS at entry | ||
0 | 46 | (66.7%) |
1 | 23 | (33.3%) |
Intervention planned at Tumour-board before inclusion | ||
Bilobectomy | 11 | (15.9%) |
Lobectomy | 36 | (52.2%) |
Pneumonectomy | 15 | (21.7%) |
Missing | 7 | (10.1%) |
Histology | ||
Adeno-NSCLC | 34 | (49.3%) |
Large-cell NSCLC | 1 | (1.5%) |
Poorly differentiated NSCLC | 5 | (7.2%) |
Squamous NSCLC | 28 | (40.6%) |
Missinga | 1 | (1.5%) |
Pack-years of smoking—median (min–max) | 40 | (3–150) |
